Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic
      QxMD      Google Scholar   
Citation:
Lancet Oncol vol 23 (2) 195-7
Year:
2022
Type:
Manuscript
Funding:
AFT
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
11
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
 
Corr. Author:
 
Authors:
             
Networks:
LAPS-MA036, LAPS-MN026   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: